Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
teprotumumab-trbw (Tepezza) 500 mg vial (OTHER 1176996160) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 2, 2026 , from http://ppman.hank.ai/transparency/procedure/1176996160/by-state?code_type=OTHER
“teprotumumab-trbw (Tepezza) 500 mg vial (OTHER 1176996160) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/1176996160/by-state?code_type=OTHER. Accessed
November 2, 2026 .
“teprotumumab-trbw (Tepezza) 500 mg vial (OTHER 1176996160) by State,” HANK Price Transparency ,
accessed November 2, 2026 ,
http://ppman.hank.ai/transparency/procedure/1176996160/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
1176996160 — Teprotumumab-trbw (Tepezza) 500 Mg Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$40,036
National median
$34,875 – $46,375
IQR (p25 – p75)
4
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$31,608
vs. negotiated
-21.1%
Hospitals reporting
4
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 1176996160 (OTHER), with interquartile range
State Median p25 p75
UT $40,036 $34,875 $46,375